Berenice’s Legacy, Ending Silence, and Serving Justice: A Call for Comprehensive Chagas Testing in the US Pediatric Population
Journal of the Pediatric Infectious Diseases Society · 2024
DOI: 10.1093/jpids/piae019 ↗Kurz gefasst
Historischer Beitrag in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2024. Verfasst von Priya Mallikarjuna und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Infectious Diseases, Mount Sinai Hospital, New York, NY, USA. Hauptthemen laut MEDLINE: Chagas Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIH.
Abstract (Originalsprache)
Berenice, a 2-year-old girl of Santa Rita, Brazil, had exhibited high-grade fevers, eyelid swelling, lymphadenopathy, and hepatosplenomegaly for a week. In 1909, Dr Carlos Chagas detected Trypanosoma cruzi in her peripheral blood, marking Berenice the first documented case of acute Chagas disease [1]. Fast-forward to present, when thousands of families embark on the journey northward to the United States/Mexico border. Last year, over 60 000 children crossed the Darien Gap, with nearly half under the age of 5 and the United States recorded nearly 83 000 children entering between January and July 2023 alone [2]. This number represents the highest proportion of displaced children globally. Throughout their travels, children face an increased risk of exposure to triatomine insects, the vector of T. cruzi [3]. Increased exposure includes the potential risk of consuming raw beverages or food contaminated with triatomine feces containing infectious T. cruzi [4]. Most infections are unrecognized and therefore undiagnosed. Upwards of 30% of individuals infected with T. cruzi will develop Chagas disease in the form of devastating cardiac, gastrointestinal, and neurologic complications decades later; these infections could have been detected and treated in childhood, preserving quality of life, but also saving millions in healthcare expenditures [5].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatric Infectious Diseases, Mount Sinai Hospital, New York, NY, USA.
- Mount Sinai Department of Environmental Medicine and Public Health, New York, NY, USA.
- Arnhold Institute for Global Health at Mount Sinai, New York, NY, USA.
- Department of Immunology, Universidad de Panama, Panamanian Investigation System and CIDES, Panama City, Panama.
- Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Universidad del Rosario, Bogota, Colombia.
Förderung
- NICHD NIH HHS
- NIH
Zitieren
APA
Mallikarjuna, P., DeFelice, N., Ward, M. J., Suarez, J. A., Ramirez, J. D., & Paniz-Mondolfi, A. (2024). Berenice’s Legacy, Ending Silence, and Serving Justice: A Call for Comprehensive Chagas Testing in the US Pediatric Population. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piae019
Vancouver
Mallikarjuna P, DeFelice N, Ward MJ, Suarez JA, Ramirez JD, Paniz-Mondolfi A. Berenice’s Legacy, Ending Silence, and Serving Justice: A Call for Comprehensive Chagas Testing in the US Pediatric Population. Journal of the Pediatric Infectious Diseases Society. 2024. doi:10.1093/jpids/piae019
BibTeX
@article{Mallikarjuna2024,
author = {Mallikarjuna, Priya and DeFelice, Nicholas and Ward, Matthew J and Suarez, Jose A and Ramirez, Juan David and Paniz-Mondolfi, Alberto},
title = {Berenice’s Legacy, Ending Silence, and Serving Justice: A Call for Comprehensive Chagas Testing in the US Pediatric Population},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2024},
doi = {10.1093/jpids/piae019}
}
EUVIMED